b 969 100
Pill imprint b 969 100 has been identified as Fluvoxamine maleate 100 mg.
Fluvoxamine is used in the treatment of obsessive compulsive disorder; anxiety and stress; social anxiety disorder; eating disorder; body dysmorphic disorder (and more), and belongs to the drug class selective serotonin reuptake inhibitors. Risk cannot be ruled out during pregnancy.
Fluvoxamine 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Fluvoxamine maleate Images
- Imprint:
-
b
969 100 - Strength:
- 100 mg
- Color:
- Brown
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- mannitol
methylcellulose (15 mPa.s)
corn starch
silicon dioxide
sodium stearyl fumarate
hypromellose 2208 (15000 mPa.s)
polyethylene glycol
polysorbate 80
ferrosoferric oxide
ferric oxide red
ferric oxide yellow
titanium dioxide
- Drug Class:
- Selective serotonin reuptake inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0969
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68115-0831 | Dispensexpress Inc (repackager) |
Note: Inactive ingredients may vary.
More Fluvoxamine Maleate resources
- Fluvoxamine (Wolters Kluwer)
- Fluvoxamine Extended-Release Capsules (Wolters Kluwer)
- fluvoxamine (Cerner Multum)
- fluvoxamine (Micromedex) - Includes Dosage Information
- Fluvoxamine Maleate (AHFS DI)
- Fluvoxamine (FDA)
- Fluvoxamine Maleate (Wolters Kluwer)


